Use of mirtazapine for the treatment of sleep disorders
View Patent ↗The invention relates to the use of mirtazapine for the preparation of a medicine for a new method of treatment of a sleep disorder in a subject, which treatment comprises the administration of mirtazapine with a unit treatment dose comprising between 0.1 and 5 mg mirtazapine and relates to a patient pack for the treatment of sleep disorders.
1. A method of treatment of primary insomnia in a subject, comprising:
administering an effective amount of mirtazapine to said subject, wherein the range of the amount is more than 0.1 to less than 5 mg mirtazapine or a pharmaceutically acceptable salt thereof.
2. The method of treatment according to claim 1 , wherein mirtazapine is the S enantiomer.
3. A method of treatment of transient sleep disorder in a subject, comprising:
administering an effective amount of more than 0.1 mg to about 4.5 mg of mirtazapine or a pharmaceutically acceptable salt thereof.
4. The method of treatment according to claim 3 , wherein mirtazapine is the S enantiomer.
5. The method of treatment according to claim 1 , wherein the range of the amount is more than 0.1 to about 4.5 mg mirtazapine.
6. The method of treatment according to claim 5 , wherein the range of the amount is about 0.5 to about 4.5 mg mirtazapine.
7. The method of treatment according to claim 3 , wherein the range of the amount is more than 0.5 to about 4.5 mg mirtazapine.
8. A method of treatment of secondary insomnia in a subject, comprising:
administering an effective amount of more than 0.1 mg to about 4.5 mg of mirtazapine or a pharmaceutically acceptable salt thereof.
9. The method of treatment according to claim 8 , wherein mirtazapine is the S enantiomer.
10. The method of treatment according to claim 8 , wherein the range of the amount is about 0.5 to about 4.5 mg mirtazapine.